The price of Lirutinib varies depending on regions, dosage specifications, medical insurance policies, and purchasing channels. According to public data, the monthly treatment cost typically ranges from several thousand to tens of thousands of yuan in China, with the specific amount subject to the medication regimen and the patient’s actual circumstances. As a prescription drug, it must be used strictly under the guidance of a physician, and the dosage shall not be adjusted or the drug purchased without authorization.
Key Factors Affecting the Price
Dosage and Treatment Course
Different indications (e.g., tumor types) require distinct dosages and treatment cycles, which may lead to a several-fold increase in costs.
Region and Purchasing Channel
There are variations in medical insurance reimbursement rates, hospital procurement prices, and retail pharmacy prices across different areas. In some regions, the drug may be included in the local supplementary medical insurance catalog.
Medical Insurance Policies
If Lirutinib is listed in the national medical insurance catalog, the out-of-pocket expense for patients will be significantly reduced (e.g., the reimbursement rate can reach 50%–70%). Specific policies shall be consulted with local authorities.
Medication Precautions
Prescription Drug Regulations
The drug must be purchased with a valid physician’s prescription. During the course of medication, regular re-examinations of liver and kidney function, blood routine, and other indicators are required.
Management of Adverse Reactions
Common side effects include skin rash, diarrhea, and thrombocytopenia. Patients should promptly communicate with their attending physicians to adjust the treatment plan if such symptoms occur.
Safety of Purchasing Channels
It is recommended to purchase the drug through hospitals or licensed pharmacies to avoid unauthorized channels and the risk of counterfeit drugs.
Cost-saving Recommendations
Contact the local medical insurance department to confirm reimbursement eligibility. Some cities offer critical illness medical care or special disease subsidies.
Keep abreast of pharmaceutical companies' patient assistance programs, as some brands provide free treatment courses or cost reductions for low-income patients.
Participate in clinical trials if eligible, which may provide free medication and more intensive medical monitoring.
Targeted cancer therapy requires individualized treatment planning. It is advisable to select the medication based on economic capacity under the guidance of an oncologist, and to stay updated on the latest changes in medical insurance policies.
